NCT01986543 Interaction Between High Dose Rifampicine and Efavirenz in Pulmonary Tuberculosis and HIV Co-infection Status UNKNOWN Phase PHASE2
NCT01985399 Neurocognitive Effects and Tolerability of Efavirenz in Aging HIV-infected Individuals ("SHAC Neuro Study") Status COMPLETED Phase N/A
NCT01980771 Barbershop Talk: HIV Prevention for African American Heterosexual Men Status COMPLETED Phase NA
NCT01978782 Pharmacokinetic Drug-drug Interaction Study Between RaltEgravir and CITALopram in Healthy Subjects (RECITAL). Status COMPLETED Phase PHASE1
NCT01978743 Advanced Neuroimaging Evaluation of CNS Changes Associated With Efavirenz Therapy Switch to an Raltegravir-based Regimen Status COMPLETED Phase NA
NCT01969461 Comparing the Effectiveness of Two Alcohol+Adherence Interventions for HIV+ Youth Status UNKNOWN Phase NA
NCT01968850 Bone Antiresorptive Therapy With Antiretroviral Initiation (BATARI) Pilot Trial Status COMPLETED Phase PHASE2
NCT01967940 Efficacy of Tenofovir Alafenamide Versus Placebo Added to a Failing Regimen Followed by Treatment With Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Plus Atazanavir in HIV-1 Positive, Antiretroviral Treatment-Experienced Adults Status COMPLETED Phase PHASE3
NCT01963234 Implementing Technology-Assisted Drug Treatment and Relapse Prevention in Federally Qualified Health Centers (FQHCs) Status COMPLETED Phase NA
NCT01962961 N-acetylcysteine to Reduce Oxidative Stress and Improve Endothelial Function in HIV-infected Older Adults Status COMPLETED Phase PHASE1/PHASE2
NCT01957917 Comparing Food and Cash Assistance for HIV-Positive Men and Women on Antiretroviral Therapy in Tanzania Status COMPLETED Phase NA
NCT01956370 Comparing the PrePex™ Device to Surgical MC for Rapid Scale Up of MC in Resource Limited Setting Status COMPLETED Phase PHASE2
NCT01951794 Validation of a Community Survey Methodology for Measuring PMTCT Program Impact Status COMPLETED Phase N/A
NCT01951092 mHealth Intervention Supporting HIV Treatment Adherence and Retention Status COMPLETED Phase NA